4-(4-(methylamino)-5-(7-((tetrahydrofuran-3-yl)oxy)-1H-indol-2-yl)imidazo[5,1-f][1,2,4]triazin-7-yl)cyclohexane-1-carboxylic acid

ID: ALA5277913

Max Phase: Preclinical

Molecular Formula: C25H28N6O4

Molecular Weight: 476.54

Associated Items:

This compound is not in our inventory system

Names and Identifiers

Canonical SMILES:  CNc1ncnn2c(C3CCC(C(=O)O)CC3)nc(-c3cc4cccc(OC5CCOC5)c4[nH]3)c12

Standard InChI:  InChI=1S/C25H28N6O4/c1-26-23-22-21(18-11-16-3-2-4-19(20(16)29-18)35-17-9-10-34-12-17)30-24(31(22)28-13-27-23)14-5-7-15(8-6-14)25(32)33/h2-4,11,13-15,17,29H,5-10,12H2,1H3,(H,32,33)(H,26,27,28)

Standard InChI Key:  SIMILLAWEZJMPE-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 35 40  0  0  0  0  0  0  0  0999 V2000
   -1.7178    0.5442    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0032    0.9565    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2912    0.5446    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2912   -0.2805    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0014   -0.6923    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7178   -0.2842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4934   -0.5355    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4934    0.7996    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.9784    0.1319    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.7070    1.5967    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1879    2.2376    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    0.6371    2.9293    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4338    2.7159    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.4769    1.8922    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.4249    3.7237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.0080    4.3072    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.8012    4.0965    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.0194    3.3017    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.7070   -1.3326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.5040   -1.5461    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.7176   -2.3432    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    1.1341   -2.9266    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.3370   -2.7131    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    0.1234   -1.9161    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.3721    3.9373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.9557    3.3538    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.0032    1.7817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    1.3476   -3.7237    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    2.1447   -3.9373    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    0.7641   -4.3072    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -0.8266    2.5392    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -1.5615    2.1647    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -2.1447    2.7477    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
   -1.7702    3.4828    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
   -0.2885    2.1942    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  2  1  2  0
  3  2  1  0
  4  3  1  0
  5  4  1  0
  1  6  1  0
  6  5  2  0
  4  7  1  0
  3  8  2  0
  8  9  1  0
  9  7  2  0
 10  8  1  0
 10 11  1  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 10  2  0
 12 15  1  0
 16 15  2  0
 17 16  1  0
 18 17  2  0
 13 18  1  0
 19  7  1  0
 19 20  1  0
 21 20  1  0
 22 21  1  0
 23 22  1  0
 19 24  1  0
 24 23  1  0
 15 25  1  0
 25 26  1  0
  2 27  1  0
 22 28  1  0
 28 29  1  0
 28 30  2  0
 31 26  1  0
 31 32  1  0
 32 33  1  0
 33 34  1  0
 34 26  1  0
 27 35  1  0
M  END

Alternative Forms

  1. Parent:

    ALA5277913

    ---

Associated Targets(Human)

MTOR Tclin Serine/threonine-protein kinase mTOR (13850 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 476.54Molecular Weight (Monoisotopic): 476.2172AlogP: 3.84#Rotatable Bonds: 6
Polar Surface Area: 126.66Molecular Species: ACIDHBA: 8HBD: 3
#RO5 Violations: HBA (Lipinski): 10HBD (Lipinski): 3#RO5 Violations (Lipinski):
CX Acidic pKa: 3.77CX Basic pKa: 2.26CX LogP: 2.77CX LogD: -0.37
Aromatic Rings: 4Heavy Atoms: 35QED Weighted: 0.38Np Likeness Score: -0.56

References

1. Chen Y, Zhou X..  (2020)  Research progress of mTOR inhibitors.,  208  [PMID:32966896] [10.1016/j.ejmech.2020.112820]

Source